Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

By the Numbers: Covid-19 Edition

A collection of facts and figures surrounding the COVID-19 pandemic
Spring/Summer 2020

By the Numbers

A collection of workers’ compensation facts and figures
Winter 2019/2020

State of the States

A roundup of regulatory activity around the country
Winter 2019/2020

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

White House Issues Executive Order on Artificial Intelligence

The order seeks increased transparency from AI companies regarding model operations, safety and privacy standards, and consumer/worker protections.
Dec 2023

Industry Wide Trends & Pharmacy Trends

Healthe expertise is featured in Risk & Insurance magazine, both on larger industry trends, and on evolving drug trends.
Dec 2023

FDA Approves New Formulation of Combogesic

The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.
Nov 2023

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

IQVIA Reports on Global Oncology Trends

Global spending on cancer therapies now exceeds $133 billion.
Jun 2018

The Craze Over Kratom

Kratom continues to grow in popularity as a drug for pain and opioid withdrawal, despite concerns from the FDA, CDC and DEA.
May 2018

WCIRB Reports on Chronic Opioid Use and Weaning

A new study analyzes the characteristics of chronic opioid use claims, while also examining opioid weaning data.
Apr 2018
1 22 23 24 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle